In experiments with mice, a rise in interleukin-1beta (IL-1beta), which occurs after myocardial infarction, led to an amplification of cardiac fibrosis and inflammation, a process which could be suppressed by the use of eplerenone. The gene discussed is IL1B; the disease is myocardial infarction.